Annexon 

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$2.56
Previous Close
$2.59
Day Range
$2.51-$2.58
52W Range
$1.28-$7.85
Market Cap
$284.1M
Shares Short
10M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$1.17

News

See more

Yahoo Finance • 7 days ago

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy

Yahoo Finance • last month

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)

Yahoo Finance • 2 months ago

Annexon Biosciences to Present at the Jefferies Global Healthcare Conference

Yahoo Finance • 2 months ago

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting

About

CEO
Mr. Douglas E. Love Esq., J.D.
CFO
Ms. Jennifer Lew CPA
Address
1400 Sierra Point Parkway, Brisbane, CA, United States, 94005
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
106